MoonLake Immunotherapeutics
MLTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001821586
In the last 90 days, MoonLake Immunotherapeutics insiders filed 0 open-market purchases and 6 sales; 172 institutions reported holding it in 13F filings for Q2 2026, worth $1.43B in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in MoonLake Immunotherapeutics as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 147
- +19 vs. Q4 2025
- Shares held
- 63.0M
- +6.96M (+12.4%) vs. Q4 2025
- Total value
- $1.17B
- +$433.9M (+58.7%) vs. Q4 2025
- New holders
- 40
- 49 more added
- Sold out
- 21
- 43 more reduced
2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MLTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 172 | $1.43B |
| Q1 2026 | 147 | $1.17B |
| Q4 2025 | 130 | $742.9M |
| Q3 2025 | 134 | $269.7M |
| Q2 2025 | 130 | $2.77B |
| Q1 2025 | 136 | $2.34B |
| Q4 2024 | 116 | $3.43B |
| Q3 2024 | 109 | $3.14B |
| Q2 2024 | 111 | $2.67B |
| Q1 2024 | 114 | $2.99B |
| Q4 2023 | 125 | $3.53B |
| Q3 2023 | 118 | $3.21B |
| Q2 2023 | 83 | $2.86B |
| Q1 2023 | 43 | $843.2M |
| Q4 2022 | 33 | $396.4M |
| Q3 2022 | 24 | $291.4M |
| Q2 2022 | 23 | $190.1M |
| Q1 2022 | 27 | $123.4M |
| Q4 2021 | 45 | $112.8M |
| Q3 2021 | 43 | $111.1M |
| Q2 2021 | 46 | $115.8M |
| Q1 2021 | 42 | $108.9M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding MoonLake Immunotherapeutics; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ishara Investments LP | 174,250 | $3.25M | 3.28% | +174,250 | New |
| Kalehua Capital Management LLC | 175,734 | $3.28M | 2.32% | 00.0% | Unchanged |
| Congress Asset Management Co | 178,555 | $3.33M | 0.02% | +107,459+151.1% | Added |
| Acuta Capital Partners, LLC | 191,760 | $3.57M | 2.54% | +132,480+223.5% | Added |
| HighVista Strategies LLC | 193,955 | $3.62M | 1.00% | +193,955 | New |
| Exome Asset Management LLC | 215,376 | $4.01M | 2.36% | +215,376 | New |
| Granahan Investment Management Inc | 220,600 | $4.11M | 0.20% | +22,293+11.2% | Added |
| Rhenman & Partners Asset Management AB | 239,500 | $4.46M | 0.55% | −124,500−34.2% | Reduced |
| BNP Paribas Arbitrage, SA | 239,838 | $4.47M | 0.00% | +228,528+2,020.6% | Added |
| Susquehanna Portfolio Strategies, LLC | 253,974 | $4.73M | 0.07% | 00.0% | Unchanged |
| Boxer Capital Management, LLC | 275,000 | $5.13M | 0.67% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 276,772 | $5.16M | 0.01% | +142,300+105.8% | Added |
| First Turn Management, LLC | 315,563 | $5.88M | 0.66% | +52,920+20.1% | Added |
| Walleye Capital LLC | 320,472 | $5.97M | 0.04% | +244,720+323.1% | Added |
| Jump Financial, LLC | 325,968 | $6.08M | 0.09% | −99,591−23.4% | Reduced |
| Susquehanna International Group, LLP | 341,424 | $6.36M | 0.01% | −207,812−37.8% | Reduced |
| Voleon Capital Management LP | 373,021 | $6.95M | 0.15% | −126,078−25.3% | Reduced |
| Longaeva Partners L.P. | 410,000 | $7.64M | 0.37% | +410,000 | New |
| Casdin Capital, LLC | 450,000 | $8.39M | 0.64% | +450,000 | New |
| Jane Street Group, LLC | 453,625 | $8.46M | 0.01% | −1,228,523−73.0% | Reduced |
| ADAR1 Capital Management, LLC | 457,137 | $8.52M | 0.51% | +457,137 | New |
| HRT Financial LP | 487,583 | $9.09M | 0.02% | −148,318−23.3% | Reduced |
| Trexquant Investment LP | 495,336 | $9.23M | 0.07% | +311,017+168.7% | Added |
| Jefferies Financial Group Inc. | 500,000 | $9.32M | 0.11% | 00.0% | Unchanged |
| Great Point Partners LLC | 500,000 | $9.32M | 2.28% | +500,000 | New |
| Millennium Management LLC | 576,092 | $10.7M | 0.01% | −226,630−28.2% | Reduced |
| Holocene Advisors, LP | 600,000 | $11.2M | 0.03% | +600,000 | New |
| Morgan Stanley | 614,482 | $11.5M | 0.00% | −430,099−41.2% | Reduced |
| Bank of America Corp | 724,794 | $13.5M | 0.00% | +711,261+5,255.8% | Added |
| Candriam Luxembourg S.C.A. | 818,126 | $15.2M | 0.08% | +683,797+509.0% | Added |
| JPMorgan Chase & Co | 1,088,514 | $18.4M | 0.00% | +250,775+29.9% | Added |
| Vivo Capital, LLC | 1,000,000 | $18.6M | 1.55% | 00.0% | Unchanged |
| BlackRock, Inc. | 1,021,851 | $19.0M | 0.00% | +735,258+256.6% | Added |
| Balyasny Asset Management LLC | 1,065,610 | $19.9M | 0.04% | −505,461−32.2% | Reduced |
| Two Sigma Investments, LP | 1,122,312 | $20.9M | 0.02% | +337,501+43.0% | Added |
| Goldman Sachs Group Inc | 1,130,233 | $21.1M | 0.00% | +859,568+317.6% | Added |
| Price T Rowe Associates Inc | 1,294,861 | $24.1M | 0.00% | +335,308+34.9% | Added |
| Citadel Advisors LLC | 1,323,728 | $24.7M | 0.02% | +942,838+247.5% | Added |
| Point72 Asset Management, L.P. | 1,368,518 | $25.5M | 0.04% | +596,018+77.2% | Added |
| Logos Global Management LP | 1,500,000 | $28.0M | 1.44% | −250,000−14.3% | Reduced |
| Weiss Asset Management LP | 1,708,328 | $31.8M | 0.58% | +1,375,367+413.1% | Added |
| MPM Oncology Impact Management LP | 1,811,082 | $33.8M | 2.61% | +1,811,082 | New |
| D. E. Shaw & Co., Inc. | 2,390,661 | $44.6M | 0.04% | −90,106−3.6% | Reduced |
| Janus Henderson Group PLC | 3,451,628 | $64.3M | 0.03% | +1,355,640+64.7% | Added |
| Cormorant Asset Management, LP | 4,480,433 | $83.5M | 4.21% | +125,000+2.9% | Added |
| Deep Track Capital, LP | 6,408,863 | $119.5M | 2.47% | +1,798,792+39.0% | Added |
| BVF Inc | 16,001,284 | $298.3M | 9.50% | −3,750,000−19.0% | Reduced |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −400,000−100.0% | Sold out |
| StemPoint Capital LP | 0 | $0 | 0.00% | −348,401−100.0% | Sold out |
| Eagle Health Investments LP | 0 | $0 | 0.00% | −187,600−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −131,700−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −130,964−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −87,390−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −50,217−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −49,168−100.0% | Sold out |
| Cinctive Capital Management LP | 0 | $0 | 0.00% | −37,194−100.0% | Sold out |
| Axiom Investors LLC | 0 | $0 | 0.00% | −25,998−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −14,920−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −13,448−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −12,291−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −11,095−100.0% | Sold out |
| Persistent Asset Partners Ltd | 0 | $0 | 0.00% | −8,523−100.0% | Sold out |
| T. Rowe Price Investment Management, Inc. | 0 | $0 | 0.00% | −3,557−100.0% | Sold out |
| Kestra Advisory Services, LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| ACT Capital Management, LLC | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −704−100.0% | Sold out |
| WPG Advisers, LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |